Document Detail

Social phobia in spasmodic torticollis.
MedLine Citation:
PMID:  11561034     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To study the prevalence of psychiatric comorbidity assessed by the use of a structured clinical interview in a large, representative sample of patients with spasmodic torticollis (ST) and to test the hypothesis that social phobia would be highly prevalent. METHODS: In a consecutive cohort of 116 patients with ST treated with botulinum toxin overall psychiatric comorbidity was studied prospectively with the structured clinical interview (SCID) for DSM-IV axis I disorders. Physical disability and psychosocial variables were also assessed with standardised self rating questionnaires. RESULTS: 41.3% of the subjects met DSM-IV clinical criteria A-G for current social phobia as the primary psychiatric diagnosis. This figure rose to 56% including secondary and tertiary psychiatric diagnosis. There was no correlation between severity of disease (Tsui score, severity of pain, body image dissatisfaction score) and psychiatric comorbidity. The only significant predictor of psychiatric comorbidity was depressive coping behaviour (logistic regression analysis, p < 0.01; OR=10.8). Compared with a representative sample of the general adult population, in the patients with ST the prevalence of clinically relevant social phobia is 10-fold, of mood disorders 2.4-fold, and of lifetime psychiatric comorbidity 2.6-fold increased. CONCLUSIONS: A particularly high prevalence of social phobia was found in the cohort of patients with ST. The finding of a high prevalence of social phobia and depressive coping behaviour as the main predictor of psychiatric comorbidity may make a subgroup of patients with ST particularly amenable to specific psychotherapeutic interventions.
H Gündel; A Wolf; V Xidara; R Busch; A O Ceballos-Baumann
Related Documents :
3596404 - Psychiatric expert testimony on aggressive offenders in juvenile court proceedings.
9572094 - The zurich long-term outcome study of child and adolescent psychiatric disorders in males.
9334524 - Psychiatric in-patient treatment for children and adolescents in the uk: criteria for a...
15180774 - Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and quali...
9019044 - Correlates of psychological distress among mothers of children and adolescents with hem...
22844164 - Counting child domestic servants in latin america.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of neurology, neurosurgery, and psychiatry     Volume:  71     ISSN:  0022-3050     ISO Abbreviation:  J. Neurol. Neurosurg. Psychiatr.     Publication Date:  2001 Oct 
Date Detail:
Created Date:  2001-09-18     Completed Date:  2001-12-04     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  2985191R     Medline TA:  J Neurol Neurosurg Psychiatry     Country:  England    
Other Details:
Languages:  eng     Pagination:  499-504     Citation Subset:  IM    
Department of Psychosomatic Medicine, Klinikum rechts der Isar, Technische Universität München, Langerstrasse 3, 81675 München, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adaptation, Psychological
Botulinum Toxin Type A / administration & dosage
Cohort Studies
Depressive Disorder / diagnosis,  epidemiology,  psychology
Injections, Intramuscular
Middle Aged
Phobic Disorders / diagnosis*,  epidemiology,  psychology
Psychiatric Status Rating Scales
Sick Role
Torticollis / drug therapy,  epidemiology,  psychology*
Reg. No./Substance:
0/Botulinum Toxin Type A
Comment In:
J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):461; author reply 461-2   [PMID:  12235327 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.
Next Document:  Perimetric visual field and functional MRI correlation: implications for image-guided surgery in occ...